Erratum: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients (Clinical Cancer Research (2020) 26 (5709-5719) DOI: 10.1158/1078-0432.CCR-20-0446)

Mitchell Fane, Brett L. Ecker, Amanpreet Kaur, Gloria E. Marino, Gretchen M. Alicea, Stephen Douglass, Yash Chhabra, Marie R. Webster, Andrea Marshall, Richard Colling, Olivia Espinosa, Nicholas Coupe, Neera Maroo, Leticia Campo, Mark R. Middleton, Pippa Corrie, Xiaowei Xu, Giorgos C. Karakousis, Ashani T. Weeraratna

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), Supplementary Fig. S4 was incorrect. The CD105 stain used to represent rsFRP2 þ alpha-VEGF for Mouse 1 was also used for Mouse 2. The authors provided the correct stain for Mouse 2 and an additional stain for Mouse 3. Supplementary Fig. S4 has been replaced with a corrected version in the latest online HTML version of the article. The authors regret the error.

Original languageEnglish (US)
Pages (from-to)2012
Number of pages1
JournalClinical Cancer Research
Volume29
Issue number10
DOIs
StatePublished - May 15 2023

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients (Clinical Cancer Research (2020) 26 (5709-5719) DOI: 10.1158/1078-0432.CCR-20-0446)'. Together they form a unique fingerprint.

Cite this